Skip to content

Use of 2-octylcyanoacrylate With Full-thickness Skin Grafts

Use of 2-octylcyanoacrylate (Dermabond) During Cutaneous Wound Closure With Full-thickness Skin Grafts: a Randomized Split Wound Comparative Effectiveness Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02550574
Enrollment
50
Registered
2015-09-15
Start date
2015-08-31
Completion date
2017-05-31
Last updated
2017-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound Closure Techniques

Brief summary

The purpose of this study is to determine whether the use of 2-octylcyanoacrylate during repair of cutaneous surgery wounds with full-thickness skin grafts improves scar cosmesis compared to wound closure with sutures.

Detailed description

The purpose of this study is to determine whether the use of 2-octylcyanoacrylate during repair of cutaneous surgery wounds with full-thickness skin grafts improves scar cosmesis compared to wound closure with sutures. Our aims are to compare outcomes using a split wound model, where half of the wound is treated with 2-octylcyanoacrylate and the other half is repaired with sutures, per the standard of care. Three-months post-surgery, the scar will be measured via the physician observer scar assessment scale, a validated scar instrument. Our hypothesis is that 2-octylcyanoacrylate will result in cosmetically superior wound outcomes.

Interventions

PROCEDUREWound Closure with 5-0 Vicryl Sutures

Sponsors

University of California, Davis
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Over 18 years of age * Able to give informed consent themselves * Patient scheduled for cutaneous surgical procedure with predicted closure with full-thickness skin graft * Willing to return for follow-up visits

Exclusion criteria

* Mentally handicapped * Unable to understand written and oral English * Incarceration * Under 18 years of age * Pregnant Women * Patients on systemic steroid therapies * Patients with Marfans * Patients with allergies to 2-octylcyanoacrylate

Design outcomes

Primary

MeasureTime frameDescription
Appearance of Scar on the Patient and Observer Scar Assessment Scale3 monthsAfter surgical procedure, half of the subject's wound will be with 2-octylcyanoacrylate, while the other half is closed 5-0 vicryl sutures. After 3 months, subjects will return to clinic for evaluation of the cosmesis of both types of closure techniques.

Secondary

MeasureTime frameDescription
Incidence of Graft Failure on Case Report3 monthsThe secondary endpoint will include incidence of graft failure (partial and complete on both sides).
Incidence of Complications on Case Report3 monthsNoting the presence or absence of bleeding, dehiscence, infection or spitting sutures.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026